Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

13D Filing: Ardsley Partners and Marrone Bio Innovations Inc (MBII)

Page 1 of 15

Marrone Bio Innovations Inc (NASDAQ:MBII): Philip Hempleman’s Ardsley Partners filed an amended 13D.

You can check out Ardsley Partners’ latest holdings and filings here.

Please follow Ardsley Partners (if you aren’t already doing so) to get real-time email alerts whenever we publish an article about Ardsley Partners or update its stock holdings.

Philip Hempleman
Philip Hempleman
Ardsley Partners

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Ardsley Advisory Partners 0 15,681,580 0 15,681,580 15,681,580 14.61%
Philip J. Hempleman 0 15,681,580 0 15,681,580 15,681,580 14.61%
Ardsley Partners I 0 15,631,580 0 15,631,580 15,631,580 14.56%
Ardsley Partners Fund II 0 595,300 0 595,300 595,300 0.58%
Ardsley Partners Advanced Healthcare Fund 0 1,189,700 0 1,189,700 1,189,700 1.17%
Ardsley Partners Renewable Energy Fund 0 13,846,580 0 13,846,580 13,846,580 12.90%
Ardsley Duckdive Fund 0 50,000 0 50,000 50,000 0.05%
Philip Hempleman
Philip Hempleman
Ardsley Partners

Page 1 of 15 – SEC Filing

SECURITIES
AND EXCHANGE COMMISSION

WASHINGTON,
DC 20549

SCHEDULE 13D

 

(Rule
13d-101)

information
to be included in statements filed pursuant

to rules 13d-1(a) and amendments thereto
filed

pursuant to rule 13d-2(a)1

Marrone
Bio Innovations, Inc.

(Name
of Issuer)

Common
Stock

(Title
of Class of Securities)

57165B106

(CUSIP
Number)

Steve
Napoli c/o Ardsley Advisory Partners

262
Harbor Drive, 4th Floor

Stamford,
Connecticut 06902

(Name,
Address and Telephone Number of Person Authorized to Receive Notice and Communications)

February
5, 2018

(Date
of Event Which Requires Filing of this Statement)

If
the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this
Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box. x

 

Note: Schedules
filed in paper format shall include a signed original and five copies of the Schedule, including all exhibits. See Rule
13d-7(b) for other parties to whom copies are to be sent.

1                 
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect
to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures
provided in a prior cover page.

 

The
information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18
of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject
to all other provisions of the Act (however, see the Notes).

Follow Marrone Bio Innovations Inc (NASDAQ:MBII)
Trade (NASDAQ:MBII) Now!
Page 1 of 15
Loading...